New York is currently home to 4480 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Adaptive Response to Intervention (RTI) for Students With ADHD
Recruiting
Purpose: The primary purpose of the proposed project is to investigate the efficacy of Tier 1 and Tier 2 interventions delivered through a Response to Intervention (RTI) framework for children with attention-deficit/hyperactivity disorder (ADHD). Further, for children who do not respond to initial Tier 2 strategies, the proposed study will assess which additional course of intervention is most effective: (1) enhanced Tier 2 strategies or (2) stimulant medication. The majority of youth with ADHD... Read More
Gender:
ALL
Ages:
All
Trial Updated:
09/06/2023
Locations: Center for Children and Families, University at Buffalo, Buffalo, New York
Conditions: Attention Deficit Disorder With Hyperactivity
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Recruiting
The study is a Phase 1dose escalation study to evaluate the safety, tolerability, and pharmacokinetics of ASKG915 as a single agent in patients with selected advanced solid tumors.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/05/2023
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Advanced Solid Tumors
Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants
Recruiting
The goal of this clinical trial is to compare sleeping in a SNOO Smart Sleeper bassinet (SNOO) with sleeping in traditional bassinet conditions in premature infants. The main questions it aims to answer are: 1. Do preterm infants who sleep in the SNOO have more quiet sleep? 2. Do preterm infants who sleep in the SNOO have improved vital signs? * Participants will spend two separate three-hour periods sleeping in either a SNOO (which plays white noise and rocks from side-to-side) or in a SNO... Read More
Gender:
ALL
Ages:
Between 1 week and 12 weeks
Trial Updated:
09/05/2023
Locations: Morgan Stanley Children's Hospital Neonatal Intensive Care Unit, NewYork Presbyterian, New York, New York
Conditions: Prematurity, Very Preterm Maturity of Infant
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
Recruiting
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
09/05/2023
Locations: James J. Peters VA, Bronx, New York
Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
09/01/2023
Locations: NY Scientific, Brooklyn, New York
Conditions: Ulcerative Colitis
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Recruiting
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and t... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: Oishei Children's Hospital University at Buffalo, Buffalo, New York
Conditions: Postpartum Hypertension
Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults
Recruiting
TENS (transcutaneous electrical nerve stimulation) is accepted as a standard treatment for chronic pelvic pain, but the best settings to recommend, including frequency of stimulation, have not been defined to date. This study aims to find the optimal frequency, also known as cycles per second or Hertz (Hz) for treating chronic pelvic pain using non-invasive skin-level electrical nerve stimulation. The investigators will see how people respond to (20Hz, 50Hz or 100Hz). The study will have a two w... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/30/2023
Locations: Albany Medical Center, Albany, New York
Conditions: Chronic Pelvic Pain
IOP Elevation Study
Recruiting
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/30/2023
Locations: NYU Langone Health, New York, New York
Conditions: Intraocular Pressure
Neurofibromatosis (NF) Registry Portal
Recruiting
The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted patient subgroups, and to supply de-identified disease data to researchers. It has the potential to become a natural history resource.
Gender:
ALL
Ages:
All
Trial Updated:
08/29/2023
Locations: Children's Tumor Fundation, New York, New York
Conditions: Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Recruiting
Congenital heart defects (CHD) are the most common major human birth malformation, affecting \~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and are second only to infectious diseases in contributing to the infant mortality rate. Current understanding of the etiology of pediatric cardiovascular disorders is limited. The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective observational cohort study. Participants will b... Read More
Gender:
ALL
Ages:
99 years and below
Trial Updated:
08/29/2023
Locations: Cohen Children's Medical Center New York, New Hyde Park, New York
Conditions: Congenital Heart Defects
rTMS and Rehabilitation for Individuals With CRPS Type 1
Recruiting
Subjects with complex regional pain syndrome (CRPS) Type 1 will be randomized to receive repeated transcranial magnetic stimulation (rTMS) followed by rehabilitation or sham rTMS followed by rehabilitation. Treatment will last for 4 weeks, with the first week including 4 rTMS treatments and 2 rehabilitation treatments. Subsequent weeks will include 2 rTMS treatments followed by 2 rehabilitation treatments. Outcome measures will include pain ratings, PROMIS questionnaires, global rating of change... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/28/2023
Locations: SUNY Upstate Medical Univeristy Institute of Human Performance, Syracuse, New York
Conditions: Complex Regional Pain Syndrome Type I
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Recruiting
This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/25/2023
Locations: Roswell Park, Buffalo, New York
Conditions: Stage IV Non-small Cell Lung Cancer, Stage IV Small Cell Lung Cancer, Stage III Malignant Melanoma, Stage IV Malignant Melanoma